Last update 17 May 2025

Emtricitabine/Efavirenz/Tenofovir disoproxil phosphate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Efavirenz/Emtricitabine/Tenofovir Disoproxil Phosphate
Target
RT
Action
inhibitors
Mechanism
RT inhibitors(Viral reverse transcriptase inhibitors)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
HIV Infections
Originator Organization
Zentiva SAZentiva SA
Active Organization-
Inactive Organization
Gilead Sciences, Inc.Gilead Sciences, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC19H33N5O14P2
InChIKeyDJCLNKKHALBVLK-PFEQFJNWSA-N
CAS Registry1453166-76-1
View All Structures (3)

Related

1
Clinical Trials associated with Emtricitabine/Efavirenz/Tenofovir disoproxil phosphate
IRCT20220211053992N29
/ RecruitingNot ApplicableIIT
In vivo bioequivalence study of Effavirenz/Emtricitabine/Tenofovir (600/200/300) manufactured by Bakhtar Bioshimi Co. compared with innovator product
100 Clinical Results associated with Emtricitabine/Efavirenz/Tenofovir disoproxil phosphate
Login to view more data
100 Translational Medicine associated with Emtricitabine/Efavirenz/Tenofovir disoproxil phosphate
Login to view more data
100 Patents (Medical) associated with Emtricitabine/Efavirenz/Tenofovir disoproxil phosphate
Login to view more data
100 Deals associated with Emtricitabine/Efavirenz/Tenofovir disoproxil phosphate
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 2
United States
Gilead Sciences, Inc.Gilead Sciences, Inc.
01 Apr 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
IAS2007
Not Applicable
HIV Infections
First line
40
aitwlmxnku(zeksfuzaeu) = yswmxvzrkc ezbogupkjn (ddvyjumybr, 102)
View more
-
01 Jan 2007
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free